Cell Maps For AI: Mapping Cellular Structure and Function

The CM4AI data generation project seeks to map the spatiotemporal architecture of human cells and use these maps toward the grand challenge of interpretable genotype-phenotype learning

Data Insights

Explore the numbers behind our innovative data generation project and see the impact we are making.

Protein Interactions

1,374

Immunofluorescent Images

53,788

Total Proteins Investigated

7,023

genes targeted

11,739

Data volume

21.4 TB

CM4AI Project Components

Data Acquisition

Teaming

Ethics

Standards

Skills & Workforce Development

Data Releases

CM4AI project is a coordinated effort involving three complementary mapping approaches – proteomic mass spectrometry, cellular imaging, and genetic perturbation via CRISPR/Cas9

Tools

CM4AI is developing tools to integrate multimodal data, with the goal of creating a library of large-scale maps of cellular structure and function across demographic and disease contexts

Publications

Check out our recent publications to learn more about how CM4AI is addressing the Bridge2AI’s Functional Genomics grand challenge

Training

CM4AI offers a wealth of educational content and a robust hands-on training program to foster biomedical AI/ML skill development

Mapping Approaches

Discover the different mapping approaches we use to generate valuable data for your research.

Proteomic Mass Spectrometry

Our cutting-edge proteomic mass spectrometry technology allows for precise mapping of cellular structure and function.

Cellular Imaging

Through advanced cellular imaging techniques, we are able to reveal the intricate details of human cells.

Genetic Perturbation via CRISPR/Cas9

Our use of CRISPR/Cas9 technology allows for targeted genetic perturbation and further insights into cellular mechanisms.

CM4AI Institutions

Join the effort towards interpretable genotype-phenotype learning

Learn more about our project and the maps we are creating to revolutionize the fields of genomics and precision medicine, through the use of advanced technologies such as proteomic mass spectrometry, cellular imaging, and genetic perturbation via CRISPR/Cas9.